APPLIED GENETIC TECHNOLOGIES (AGTC) Stock Balance Sheet
NASDAQ:AGTC - Nasdaq - US03820J1007 - Common Stock - Currency: USD
| MRQ (2022-9-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | 2019 (2019-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 34.24M | 46.37M | 105.05M | 38.50M | 26.70M | |||
| Marketable Securities | N/A | 0.00 | 2.00M | 42.00M | 55.30M | |||
| Receivables | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other Current Assets | 3.00M | 3.19M | 2.65M | 2.50M | 2.30M | |||
| Total Current Assets | 37.24M | 49.56M | 109.71M | 83.00M | 84.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.77M | 7.76M | 7.86M | 7.80M | 4.40M | |||
| Investments And Advances | 7.73M | 7.81M | 8.00M | 8.10M | 1.90M | |||
| Intangibles | 1.54M | 1.43M | 1.29M | 1.10M | 1.00M | |||
| Other Non-Current Assets | 3.05M | 126.00K | 113.00K | 300.00K | 500.00K | |||
| Total Non-Current Assets | 20.09M | 17.12M | 17.26M | 17.30M | 7.90M | |||
| TOTAL ASSETS | 57.33M | 66.68M | 126.97M | 100.30M | 92.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 9.53M | 9.30M | 2.22M | 0.00 | N/A | |||
| Accrued Expenses | 13.03M | 13.00M | 15.62M | 11.60M | 8.00M | |||
| Accounts Payable | 4.04M | 2.91M | 1.88M | 1.40M | 1.30M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 26.60M | 25.21M | 19.71M | 13.00M | 9.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.81M | 9.12M | 17.73M | 9.70M | 0.00 | |||
| Other Non-Current Liabilities | 6.27M | 2.88M | 3.72M | 6.60M | 4.20M | |||
| Total Non-Current Liabilities | 13.08M | 12.00M | 21.44M | 16.30M | 4.10M | |||
| TOTAL LIABILITIES | 39.69M | 37.21M | 41.16M | 29.30M | 13.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -326.62M | -308.21M | -239.27M | -181.40M | -135.50M | |||
| Additional Paid In Capital | 344.46M | 337.89M | 325.25M | 252.50M | 214.30M | |||
| Common Shares | 68.00K | 51.00K | 43.00K | 0.00 | 0.00 | |||
| Treasury Stock | -256.00K | -256.00K | -211.00K | -100.00K | -100.00K | |||
| Shares Outstanding | 67.63M | 50.96M | 42.79M | 25.80M | 18.20M | |||
| Tangible Book Value per Share | 0.24 | 0.55 | 1.98 | 2.71 | 4.27 | |||
| Total Shareholders' Equity | 17.65M | 29.48M | 85.81M | 71.00M | 78.70M | |||
| TOTAL LIABILITIES AND EQUITY | 57.33M | 66.68M | 126.97M | 100.30M | 92.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.39 | 0.31 | 0.21 | 0.14 | N/A | |||
| Current Ratio | 1.40 | 1.97 | 5.56 | 6.38 | 8.97 | |||
| Return On Assets (ROA) | -122.50% | -103.39% | -45.55% | -45.75% | -2.18% | |||
| Return On Equity (ROE) | -398.02% | -233.89% | -67.39% | -64.63% | -2.55% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21